Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsTOPICALStandard

EXELDERM

SULCONAZOLE NITRATE

Standard Dose
1%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview EXELDERM is listed in Drugs@FDA under application 018737 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient SULCONAZOLE NITRATE Form and strength CREAM;TOPICAL - 1% Sponsor JOURNEY Submission history Latest submission status date: 2013-11-26 00:00:00.

Structured Monograph

Clinical summary

Approval overview EXELDERM is listed in Drugs@FDA under application 018737 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient SULCONAZOLE NITRATE Form and strength CREAM;TOPICAL - 1% Sponsor JOURNEY Submission history Latest submission status date: 2013-11-26 00:00:00. Submission type: SUPPL.

Monitoring

  • Marketing status: Prescription
  • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.